Orbsen Therapeutics Limited

Orbsen Therapeutics Limited is an SME in Galway, Ireland that has taken part in 8 EU-funded projects since 2008, receiving €4.1M in EU funding.

EU funding received€4.1M
EU projects8
As coordinator0
Running now0
First EU project2008
Latest project2016
CountryIreland
EU registration (PIC)998273658
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Orbsen Therapeutics Limited's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.9M · 5 projects
  • Horizon 2020€1.1M · 3 projects

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • AUTOSTEMPartner

    Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient”

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €448ktheir share
  • BrainMatTrainPartner

    Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €266ktheir share
  • NEPHSTROMPartner

    Novel Stromal Cell Therapy for Diabetic Kidney Disease

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €397ktheir share
  • VISICORTPartner

    Adverse Immune Signatures and their Prevention in Corneal Transplantation

    FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗

    €451ktheir share
  • MERLINPartner

    MEsenchymal stem cells to Reduce Liver INflammation

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €932ktheir share
  • DECIDEPartner

    Decision-making within cells and differentiation entity therapies

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €245ktheir share
  • REDDSTARPartner

    Repair of Diabetic Damage by Stromal Cell Administration

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €1.1Mtheir share
  • PURSTEMPartner

    Utilisation of the mesenchymal stem cell receptome for rational development of uniform, serum-free culture conditions and tools for cell characterization

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €256ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • animal husbandry
  • continuous glucose monitors
  • diabetic nephropathy
  • hepatology
  • immunology
  • implants
  • kidney diseases
  • leukemia
  • mortality
  • nanomedicine
  • nanotechnology
  • ophthalmology
  • parkinson
  • pathology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime